Prestige Consumer (PBH) SVP sells 351 shares at $52.28

Rhea-AI Filing Summary

Prestige Consumer Healthcare Inc. Senior VP Operations Jeffrey Zerillo reported an open-market sale of 351 shares of common stock on May 11, 2026 at $52.28 per share. After this transaction, he directly owns 41,810 shares of Prestige Consumer Healthcare common stock.

Insider Trade Summary 10b5-1

Net Seller: 351 shares

Net Sell 1 txn

Insider Zerillo Jeffrey

Role Senior VP Operations

Sold 351 shs ($18K)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share	351	$52.28	$18K

Holdings After Transaction: Common Stock, par value $0.01 per share — 41,810 shares (Direct)

Key Figures

Shares sold: 351 shares Sale price per share: $52.28 per share Shares owned after transaction: 41,810 shares +1 more

4 metrics

Shares sold 351 shares Open-market sale on May 11, 2026

Sale price per share $52.28 per share Transaction price for common stock

Shares owned after transaction 41,810 shares Direct ownership following sale

Net shares sold 351 shares Net buy/sell shares in this Form 4

Key Terms

Common Stock, par value $0.01 per share, open-market sale, direct ownership

3 terms

Common Stock, par value $0.01 per share financial

"security_title: Common Stock, par value $0.01 per share"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

direct ownership financial

"ownership_type: direct, ownership_code: D"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 05/12/2026 - 04:01 PM Learn about SEC filing dates

FAQ

What insider transaction did Prestige Consumer Healthcare (PBH) report?

Prestige Consumer Healthcare reported an insider sale of shares. Senior VP Operations Jeffrey Zerillo sold 351 shares of common stock in an open-market transaction at $52.28 per share, according to a Form 4 insider trading report.

How many Prestige Consumer Healthcare (PBH) shares did Jeffrey Zerillo sell?

Jeffrey Zerillo sold 351 PBH shares. The Senior VP Operations executed an open-market sale of 351 shares of Prestige Consumer Healthcare common stock, as disclosed in the Form 4 insider transaction filing.

At what price were Jeffrey Zerillo’s PBH shares sold?

The PBH shares were sold at $52.28 each. The Form 4 filing shows that Senior VP Operations Jeffrey Zerillo completed an open-market sale of 351 Prestige Consumer Healthcare common stock shares at a transaction price of $52.28 per share.

How many Prestige Consumer Healthcare (PBH) shares does Jeffrey Zerillo hold after the sale?

Jeffrey Zerillo holds 41,810 PBH shares after the sale. Following the open-market transaction of 351 shares, the Form 4 reports his direct ownership position in Prestige Consumer Healthcare common stock as 41,810 shares.

Was the Prestige Consumer Healthcare (PBH) insider transaction a buy or a sell?

The disclosed PBH insider transaction was a sale. Form 4 data identify the transaction code as “S,” indicating an open-market sale of 351 shares of Prestige Consumer Healthcare common stock by Senior VP Operations Jeffrey Zerillo.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zerillo Jeffrey

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/11/2026		S		351	D	$52.28	41,810	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeffrey Zerillo by William P'Pool as attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)